Kashyap Tele-Medicines Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 679992,
    "name": "Kashyap TeleMed.",
    "stock_name": "Kashyap TeleMed.",
    "full_name": "Kashyap Tele-Medicines Ltd",
    "name_url": "stocks-analysis/kashyap-telemed",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "6.19",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "6.19",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531960,
    "symbol": "",
    "ind_name": "Computers - Software & Consulting",
    "ind_code": 57,
    "indexname": "",
    "isin": "INE108B01029",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "15.6 k",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kashyap-telemed-679992-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Kashyap TeleMed.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kashyap-telemed-3709199",
        "imagepath": "",
        "date": "2025-11-17 23:23:15",
        "description": "Answer:\nThe historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'..."
      },
      {
        "title": "How has been the historical performance of Kashyap TeleMed.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kashyap-telemed-3695664",
        "imagepath": "",
        "date": "2025-11-13 00:34:42",
        "description": "Answer:\nThe historical performance of Kashyap TeleMed shows a consistent trend in net sales, remaining stable at 0.19 Cr in both Mar'24 and Mar'25, with a slight decline from 0.20 Cr in Mar'23 and Mar'22. Total operating income mirrored this stability, holding at 0.19 Cr in the latest two years. However, total expenditure, excluding depreciation, decreased from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25, indicating a reduction in costs. Despite this, the operating profit (PBDIT) has fluctuated, showing a loss of 0.03 Cr in Mar'24 and breaking even in Mar'25, after a profit of 0.01 Cr in Mar'23. Profit before tax also reflected this trend, with a loss of 0.03 Cr in Mar'24 and no profit in the following year. Profit after tax remained at zero in Mar'25, following a loss of 0.03 Cr in Mar'24 and a break-even in Mar'23. The earnings per share (EPS) have been negative in recent years, with a value of 0.0 in Mar'25 a..."
      }
    ],
    "total": 14,
    "sid": "679992",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kashyap-tele-medicines-679992"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-Jan-2026",
      "details": "Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Unaudited results for quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "07-Jan-2026",
      "details": "This is in continuation of the Corporate Announcements submitted by the Company on August 14 2025 under Reg 30 of the SEBI (LODR) Regulations 2015 intimating the resignation of Directors and pursuant to the email directions received from BSE Limited seeking additional details in terms of SEBI circular no SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Regulation 74(5) along with RTAs certificate",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Kashyap TeleMed.?

2025-11-17 23:23:15

Answer: The historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'...

How has been the historical performance of Kashyap TeleMed.?

2025-11-13 00:34:42

Answer: The historical performance of Kashyap TeleMed shows a consistent trend in net sales, remaining stable at 0.19 Cr in both Mar'24 and Mar'25, with a slight decline from 0.20 Cr in Mar'23 and Mar'22. Total operating income mirrored this stability, holding at 0.19 Cr in the latest two years. However, total expenditure, excluding depreciation, decreased from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25, indicating a reduction in costs. Despite this, the operating profit (PBDIT) has fluctuated, showing a loss of 0.03 Cr in Mar'24 and breaking even in Mar'25, after a profit of 0.01 Cr in Mar'23. Profit before tax also reflected this trend, with a loss of 0.03 Cr in Mar'24 and no profit in the following year. Profit after tax remained at zero in Mar'25, following a loss of 0.03 Cr in Mar'24 and a break-even in Mar'23. The earnings per share (EPS) have been negative in recent years, with a value of 0.0 in Mar'25 a...

View All News